Earnings Feed
Start Free
ANGIOTECH PHARMACEUTICALS INC·4/A

May 17, 6:52 PM ET

Neske Tammy 4/A

4/A · ANGIOTECH PHARMACEUTICALS INC · Filed May 17, 2011

Insider Transaction Report

Form 4/AAmended
Period: 2011-05-12
ANGIOTECH PHARMACEUTICALS INCANPI
Neske Tammy
SVP, Human Resources
Transactions
  • Other

    Common Stock

    2011-05-12−3,000→ 8,800 total
  • Other

    Common Stock

    2011-05-12−5,500→ 0 total
  • Other

    Stock Option w/Tandem SAR

    2011-05-12−85,000→ 350,000 total
    Exercise: $1.09From: 2010-04-01Exp: 2015-03-07→ Common Stock (85,000 underlying)
  • Other

    Stock Option w/Tandem SAR

    2011-05-12−50,000→ 0 total
    Exercise: $8.90From: 2007-03-01Exp: 2012-02-04→ Common Stock (50,000 underlying)
  • Other

    Stock Option w/Tandem SAR

    2011-05-12−150,000→ 200,000 total
    Exercise: $0.38From: 2009-04-01Exp: 2014-03-09→ Common Stock (150,000 underlying)
  • Other

    Common Stock

    2011-05-12−3,300→ 5,500 total
  • Other

    Stock Option w/Tandem SAR

    2011-05-12−150,000→ 50,000 total
    Exercise: $0.21From: 2009-01-01Exp: 2013-12-07→ Common Stock (150,000 underlying)
Footnotes (2)
  • [F1]Effective on May 12, 2011, all of the Company's existing common shares and options to acquire common shares were canceled without any payment or consideration therefor, in connection with the implementation of a plan of compromise or arrangement under the Companies' Creditors Arrangement Act (Canada).
  • [F2]Price is in Canadian $.

Documents

1 file
  • 4
    primary_doc.xml

    PRIMARY DOCUMENT